文献速递腹部CTMR

LI-RADS 2018版用于MRI和CT的阅片者间信度多中心评估

A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT.
PubMed 文献 · Radiology · 2023-01-01

该回顾性多中心研究纳入6家机构3个国家的484例患者(93例CT、391例MRI),由43名研究阅片者独立评分,评估LI-RADS 2018版阅片者间一致性。有序LI-RADS、恶性二分法、LR-5和LR-M的ICC分别为0.68、0.63、0.58和0.46,总体为中等一致性;部分比较中研究间阅片一致性高于研究与临床阅片间一致性,提示临床与研究环境存在差异,需进一步研究。

要点

  • 有序LI-RADS的ICC为0.68(95%CI 0.61–0.73),总体为中等一致性。
  • 恶性二分法ICC为0.63(95%CI 0.55–0.70),LR-5的ICC为0.58(95%CI 0.50–0.66),LR-M的ICC为0.46(95%CI 0.31–0.61)。
  • 研究间阅片一致性高于研究与临床阅片间一致性:有序LI-RADS的ICC为0.68 vs 0.62(P=0.03),恶性二分法为0.63 vs 0.53(P=0.005),LR-5和LR-M无显著差异。

核心结论

  • LI-RADS 2018版总体为中等一致性。
  • 部分比较中研究间阅片一致性高于研究与临床阅片间一致性,提示临床与研究环境存在差异,需进一步研究。

研究设计与样本

  • 回顾性研究,使用来自6家机构3个国家的去标识临床多期CT和MRI及报告,每份检查至少有一个未经治疗的观察灶。
  • 共纳入484例患者(平均年龄62岁±10[SD];156名女性;93例CT检查,391例MRI检查),每份检查随机分配2名研究阅片者(共43名)独立评分。
  • 以临床报告提取的特征计算LI-RADS 2018版分类作为再评分临床读片,并与研究阅片者评分比较。

诊断标准与关键数值

  • 有序改良四分类LI-RADS量表的ICC为0.68(95%CI 0.61–0.73)。
  • 恶性二分法(LR-4、LR-5、LR-M和LR-TIV)的ICC为0.63(95%CI 0.55–0.70)。
  • LR-5的ICC为0.58(95%CI 0.50–0.66);LR-M的ICC为0.46(95%CI 0.31–0.61)。

临床应用与阅片要点

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

Background Various limitations have impacted research evaluating reader agreement for Liver Imaging Reporting and Data System (LI-RADS). Purpose To assess reader agreement of LI-RADS in an international multicenter multireader setting using scrollable images. Materials and Methods This retrospective study used deidentified clinical multiphase CT and MRI and reports with at least one untreated observation from six institutions and three countries; only qualifying examinations were submitted. Examination dates were October 2017 to August 2018 at the coordinating center. One untreated observation per examination was randomly selected using observation identifiers, and its clinically assigned features were extracted from the report. The corresponding LI-RADS version 2018 category was computed as a rescored clinical read. Each examination was randomly assigned to two of 43 research readers who independently scored the observation. Agreement for an ordinal modified four-category LI-RADS scale (LR-1, definitely benign; LR-2, probably benign; LR-3, intermediate probability of malignancy; LR-4, probably hepatocellular carcinoma [HCC]; LR-5, definitely HCC; LR-M, probably malignant but not HCC specific; and LR-TIV, tumor in vein) was computed using intraclass correlation coefficients (ICCs). Agreement was also computed for dichotomized malignancy (LR-4, LR-5, LR-M, and LR-TIV), LR-5, and LR-M. Agreement was compared between research-versus-research reads and research-versus-clinical reads. Results The study population consisted of 484 patients (mean age, 62 years ± 10 [SD]; 156 women; 93 CT examinations, 391 MRI examinations). ICCs for ordinal LI-RADS, dichotomized malignancy, LR-5, and LR-M were 0.68 (95% CI: 0.61, 0.73), 0.63 (95% CI: 0.55, 0.70), 0.58 (95% CI: 0.50, 0.66), and 0.46 (95% CI: 0.31, 0.61) respectively. Research-versus-research reader agreement was higher than research-versus-clinical agreement for modified four-category LI-RADS (ICC, 0.68 vs 0.62, respectively; P = .03) and for dichotomized malignancy (ICC, 0.63 vs 0.53, respectively; P = .005), but not for LR-5 (P = .14) or LR-M (P = .94). Conclusion There was moderate agreement for LI-RADS version 2018 overall. For some comparisons, research-versus-research reader agreement was higher than research-versus-clinical reader agreement, indicating differences between the clinical and research environments that warrant further study. © RSNA, 2023 Supplemental material is available for this article. See also the editorials by Johnson and Galgano and Smith in this issue.

来源:Radiology,查看原文。版权归原作者所有。

引用

  1. Hong CW, Chernyak V, Choi JY, et al. A Multicenter Assessment of Interreader Reliability of LI-RADS Version 2018 for MRI and CT. Radiology. 2023. PMID: 37367445. doi:10.1148/radiol.222855

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。